Refine Biology Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 200

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $14.2M

  • Investors
  • 6

Refine Biology General Information

Description

Producer of stevia and erythritol intended to develop healthier, aesthetically appealing, functionally enhanced products with reliable safety and regulatory compliance. The company offers non-sugar beverages, stevia and erythritol, thereby providing customers with healthy and tasty goods.

Contact Information

Website
www.refinebiology.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room A203, Building B-2, Dongsheng Science and Technology Park
  • Number 66 Xixiaokou Road, Haidian District
  • Beijing
  • China
+86 010
Primary Industry
Food Products
Vertical(s)
FoodTech, Manufacturing
Corporate Office
  • Room A203, Building B-2, Dongsheng Science and Technology Park
  • Number 66 Xixiaokou Road, Haidian District
  • Beijing
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Refine Biology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 29-Dec-2025 $14.2M Completed Generating Revenue
3. Later Stage VC (Series B) 20-Aug-2021 Completed Generating Revenue
2. Later Stage VC (Series A) 27-Apr-2021 Completed Generating Revenue
1. IPO 11-Nov-2016 Completed Generating Revenue
To view Refine Biology’s complete valuation and funding history, request access »

Refine Biology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Refine Biology Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
JIF Capital Venture Capital Minority
Xingxiang Investment Holding Group Asset Manager Minority
Cowin Capital Venture Capital Minority
Hangzhou Datou Investment Management Venture Capital Minority
Jiangsu Xingnahe Investment Management Company Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Refine Biology FAQs

  • When was Refine Biology founded?

    Refine Biology was founded in 2007.

  • Where is Refine Biology headquartered?

    Refine Biology is headquartered in Beijing, China.

  • What is the size of Refine Biology?

    Refine Biology has 200 total employees.

  • What industry is Refine Biology in?

    Refine Biology’s primary industry is Food Products.

  • Is Refine Biology a private or public company?

    Refine Biology is a Private company.

  • What is Refine Biology’s current revenue?

    The current revenue for Refine Biology is .

  • How much funding has Refine Biology raised over time?

    Refine Biology has raised $29.6M.

  • Who are Refine Biology’s investors?

    JIF Capital, Xingxiang Investment Holding Group, Cowin Capital, Hangzhou Datou Investment Management, and Jiangsu Xingnahe Investment Management Company are 5 of 6 investors who have invested in Refine Biology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process